Collagen has no single "how long". The trials measured very different things, and each runs on its own clock: a blood marker of collagen-making within the 3-day study, recovery from a muscle-damaging workout within two days, joint pain and fat-free mass at 12 weeks, tendon size at 14 weeks, bone density at 12 months. And in most trials the outcome was measured only at the start and the end — so they show a change had arrived by the last visit, not when it started.
This page sets out, endpoint by endpoint, how long each trial ran, when it measured, and what had or had not changed. It reuses the trials already read on the collagen evidence index and adds their timing. Amounts are reported from the trials, never recommended. Skin and hair run on a separate evidence base, covered by Peptide Glow Journal's collagen peptides for hair and skin.
The timeline table
| Endpoint | Trial | Who | Amount | Measured at | First change measured |
|---|---|---|---|---|---|
| Blood marker of collagen synthesis | Shaw 2017 | 8 men, crossover | 5 or 15 g gelatin + vitamin C, 1 h before 6 min of rope-skipping, 3 times a day | 4, 24, 48 and 72 h | within the 3-day study (15 g doubled the marker vs placebo) |
| Muscle soreness and jump recovery | Clifford 2019 | 24 active men | 20 g/day, 7 days before and 2 days after 150 drop jumps | 1.5, 24 and 48 h after exercise | by 48 h (moderate benefit; soreness p = 0.071) |
| Muscle protein synthesis | Oikawa 2020 | 22 older women | 30 g twice a day, 6 days | acute and over 6 days | none for collagen; whey raised it |
| Joint pain with activity | Zdzieblik 2017 | 139 athletes with knee pain | 5 g/day | baseline and 12 weeks | 12 weeks (activity pain −19.5 vs −13.9; rest pain no difference) |
| Joint pain in young active adults | Zdzieblik 2021 | 180 adults 18–30 | specific collagen peptides | baseline and 12 weeks | 12 weeks (exercise pain only) |
| Joint pain in athletes | Clark 2008 | 147 athletes, 97 analysed | 10 g/day | over 24 weeks | by 24 weeks (six pain measures) |
| Pain and daily activity | Kviatkovsky 2023 | middle-aged active adults | 10 or 20 g/day | 3, 6 and 9 months | over 6 months on 10 g (pain only if >180 min exercise a week); mental-health score on 10 g over 3–9 months |
| Knee score, undenatured type II | Möller 2026 | 74 healthy adults | 40 mg/day, 180 days | several visits to day 180 | both groups improved by day 180; collagen group improved from baseline earlier on some sub-scores |
| Fat-free mass with training | Zdzieblik 2015 | 53 older men with sarcopenia | 15 g/day | baseline and 12 weeks | 12 weeks (+4.2 vs +2.9 kg) |
| Fat-free mass with training | Jendricke 2019 | 77 premenopausal women | 15 g/day | baseline and 12 weeks | 12 weeks |
| Tendon size with training | Jerger 2022 | 40 young men | 5 g/day | baseline and 14 weeks | 14 weeks (tendon area +11.0 vs +4.7%; stiffness and strength no difference) |
| Bone-turnover markers | Cúneo 2010 | 71 postmenopausal women | 10 g/day | baseline, 12 and 24 weeks | none at either point |
| Bone mineral density | König 2018 | 131 postmenopausal women | 5 g/day | baseline and 12 months | 12 months (spine T-score +0.10 vs −0.03) |
"First change measured" means the first visit at which the trial reported a difference — not the day the change began. Where only two visits exist, the answer is "somewhere before the final one".
Reading the table
Fast endpoints are markers, not outcomes. The two results inside a week — a blood marker of collagen-making and two days of soreness and jump recovery — describe what happens around a workout. Neither shows a stronger joint, tendon or bone. Shaw's trial is the basis for the "15 g of gelatin with vitamin C before exercise" protocols circulating in sport; it measured a marker in eight men over three days.
Most "12 weeks" answers are study-length answers. The Freiburg joint and muscle trials were designed as 12-week studies with a start and end measurement. A change that was there at week 12 might have been there at week 6; no trial checked.
The longest joint trial is the most informative on timing, and the least tidy. Kviatkovsky's 9-month trial is the only active-adult collagen-peptide trial read here with three follow-up points. Its pain improvement appeared over 6 months on 10 g, but only in people exercising more than 180 minutes a week, and the 20 g group did not show the same daily-activity change.
Placebo groups improve too. In most of the joint trials both groups' pain fell; the result is the gap between them. In the 2026 undenatured-collagen trial both groups had improved by day 180, and the difference was in how early. A person who "feels it working" at week four is reporting something the placebo arms also reported. Bongers 2020, a 12-week trial in 167 older active adults, found pain falling slightly more on placebo (−1.9) than on collagen (−1.6); it is read with the other joint trials on the joint-pain evidence page.
Some clocks never started. Bone-turnover markers did not move at 12 or 24 weeks on 10 g a day; in König's trial, the bone-density change came at 12 months. Collagen for bones reads both, with who paid for each.
What the trials did not measure
- When a change begins. With start-and-end designs, the onset is unknown for every endpoint at 12 weeks or more.
- What happens after stopping. Except for skin, no trial read here followed participants after the last dose.
- Muscle without training. The fat-free-mass trials combined collagen with supervised resistance training; collagen alone was not tested. How collagen compares with whey for muscle is on collagen peptides for muscle growth.
- Independent replication. Several of the positive trials used one manufacturer's peptides and declared its support or an author from its research institute; the evidence index lists the funding trial by trial.
How much collagen each trial gave, and how labels compare, is on how much collagen per day. The creatine equivalent of this page is how long creatine takes to work, where muscle saturation was measured by biopsy and the clock is days to weeks.
Limits of this page
Timing was read from each trial's abstract and from this site's existing reading of the papers; full texts were not reopened for interim data tonight, so an unreported interim visit could exist. The table covers the trials this site has read on the muscle, joint, tendon and bone axis, not every collagen trial. Pain endpoints are self-reported. Anyone with joint pain, an injury or low bone density has a question for a clinician about what to measure and when.
Sources and dates
All abstracts read through PubMed E-utilities on 2026-10-28.
- Shaw G, Lee-Barthel A, Ross ML, Wang B, Baar K. Vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis. Am J Clin Nutr 2017;105:136–43 — PMID 27852613
- Clifford T, Ventress M, Allerton DM, et al. The effects of collagen peptides on muscle damage, inflammation and bone turnover following exercise: a randomized, controlled trial. Amino Acids 2019;51:691–704 — PMID 30783776
- Oikawa SY, Kamal MJ, Webb EK, et al. Whey protein but not collagen peptides stimulate acute and longer-term muscle protein synthesis with and without resistance exercise in healthy older women. Am J Clin Nutr 2020;111:708–18 — PMID 31919527
- Zdzieblik D, Oesser S, Gollhofer A, König D. Improvement of activity-related knee joint discomfort following supplementation of specific collagen peptides. Appl Physiol Nutr Metab 2017;42:588–95 — PMID 28177710
- Zdzieblik D, Brame J, Oesser S, Gollhofer A, König D. The influence of specific bioactive collagen peptides on knee joint discomfort in young physically active adults. Nutrients 2021;13:523 — PMID 33562729
- Clark KL, Sebastianelli W, Flechsenhar KR, et al. 24-week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin 2008;24:1485–96 — PMID 18416885
- Kviatkovsky SA, Hickner RC, Cabre HE, Small SD, Ormsbee MJ. Collagen peptides supplementation improves function, pain, and physical and mental outcomes in active adults. J Int Soc Sports Nutr 2023;20:2243252 — PMID 37551682
- Möller I, Martínez K, Terradillos-Guillén A, et al. Efficacy and tolerability of native (undenatured) type II collagen supplementation for joint health in healthy volunteers: a randomized double-blind placebo-controlled study. Nutr J 2026;25:46 — PMID 41787523
- Zdzieblik D, Oesser S, Baumstark MW, Gollhofer A, König D. Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men. Br J Nutr 2015;114:1237–45 — PMID 26353786
- Jendricke P, Centner C, Zdzieblik D, Gollhofer A, König D. Specific collagen peptides in combination with resistance training improve body composition and regional muscle strength in premenopausal women. Nutrients 2019;11:892 — PMID 31010031
- Jerger S, Centner C, Lauber B, et al. Effects of specific collagen peptide supplementation combined with resistance training on Achilles tendon properties. Scand J Med Sci Sports 2022;32:1131–41 — PMID 35403756
- Cúneo F, Costa-Paiva L, Pinto-Neto AM, Morais SS, Amaya-Farfan J. Effect of dietary supplementation with collagen hydrolysates on bone metabolism of postmenopausal women with low mineral density. Maturitas 2010;65:253–7 — PMID 19892499
- König D, Oesser S, Scharla S, Zdzieblik D, Gollhofer A. Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women. Nutrients 2018;10:97 — PMID 29337906
- Proksch E, Segger D, Degwert J, et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol 2014;27:47–55 — PMID 23949208
- Bongers CCWG, Ten Haaf DSM, Catoire M, et al. Effectiveness of collagen supplementation on pain scores in healthy individuals with self-reported knee pain: a randomized controlled trial. Appl Physiol Nutr Metab 2020;45:793–800 — PMID 31990581 (design from the abstract; pain changes as read on this site's collagen-for-joints page).